Market Cap 564.91B
Revenue (ttm) 94.19B
Net Income (ttm) 26.80B
EPS (ttm) N/A
PE Ratio 21.58
Forward PE 20.21
Profit Margin 28.46%
Debt to Equity Ratio 0.50
Volume 8,268,365
Avg Vol 8,832,632
Day's Range N/A - N/A
Shares Out 2.41B
Stochastic %K 91%
Beta 0.35
Analysts Strong Sell
Price Target $233.28

Company Profile

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 732 524 0400
Website: www.jnj.com
Address:
One Johnson & Johnson Plaza, New Brunswick, United States
CrystalW0lfe
CrystalW0lfe Feb. 6 at 7:12 PM
0 · Reply
CrystalW0lfe
CrystalW0lfe Feb. 6 at 6:22 PM
0 · Reply
TalkMarkets
TalkMarkets Feb. 6 at 5:57 PM
#JohnsonJohnson Is A Resilient Blue-Chip Stock And It Just Hit New All-Time Highs $JNJ https://talkmarkets.com/content/stocks--equities/johnson--johnson-is-a-resilient-blue-chip-stock-and-it-just-hit-new-all-time-highs?post=555570
0 · Reply
HydrogenH2
HydrogenH2 Feb. 6 at 5:15 PM
$JNJ I'm out !!
1 · Reply
CrystalW0lfe
CrystalW0lfe Feb. 6 at 4:38 PM
0 · Reply
LibertarianTreehugger
LibertarianTreehugger Feb. 6 at 4:32 PM
AbbVie CSO Touts ‘Breakthrough Type Therapy’ Psychedelic as J&J’s Spravato Keeps Growing $JNJ $CMPS $DFTX $ABBV https://www.biospace.com/drug-development/abbvie-cso-touts-breakthrough-type-therapy-psychedelic-as-j-js-spravato-keeps-growing.
1 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 6 at 2:38 PM
$JNJ RSI: 95.05, MACD: 7.3092 Vol: 9.09, MA20: 223.14, MA50: 213.24 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
CapitalGuidanceFramework
CapitalGuidanceFramework Feb. 6 at 2:18 PM
$XOM $JNJ Energy and healthcare leaders
0 · Reply
Fabiola_T
Fabiola_T Feb. 6 at 11:49 AM
$JNJ above 50D pressing new highs
0 · Reply
Suite510
Suite510 Feb. 6 at 3:49 AM
$JNJ $KVUE $UBER lol 😂 the party 🍿 just getting started 8.5M verdict-awarded-in-first-federal-trial-over-sexual-assault-of-uber-rider JNJ your turn now 😂🤓
1 · Reply
Latest News on JNJ
The Big 3: JNJ, XOM, KO

Feb 5, 2026, 1:00 PM EST - 1 day ago

The Big 3: JNJ, XOM, KO

XOM KO


What's Behind The 50% Surge In JNJ Stock?

Feb 3, 2026, 8:47 AM EST - 3 days ago

What's Behind The 50% Surge In JNJ Stock?


Ariel Focus Fund Q4 2025 Portfolio Review

Feb 1, 2026, 10:35 AM EST - 5 days ago

Ariel Focus Fund Q4 2025 Portfolio Review

ADT AMG B FISV MOS ORCL


This Winning Fund Pro Likes J&J, Lowe's, and Utility Stocks

Jan 29, 2026, 12:42 PM EST - 8 days ago

This Winning Fund Pro Likes J&J, Lowe's, and Utility Stocks

LOW


Johnson & Johnson: Strong Momentum Heading Into 2026

Jan 28, 2026, 9:38 AM EST - 9 days ago

Johnson & Johnson: Strong Momentum Heading Into 2026


Best Dividend Kings: January 2026

Jan 25, 2026, 10:11 PM EST - 11 days ago

Best Dividend Kings: January 2026

ABBV ABM ABT ADM ADP AWR BDX


Johnson & Johnson is doing 'great things for patients,' CFO says

Jan 22, 2026, 12:15 AM EST - 15 days ago

Johnson & Johnson is doing 'great things for patients,' CFO says


Johnson & Johnson (JNJ) Q4 2025 Earnings Call Transcript

Jan 21, 2026, 1:56 PM EST - 16 days ago

Johnson & Johnson (JNJ) Q4 2025 Earnings Call Transcript


Nasdaq Edges Lower; Johnson & Johnson Earnings Top Estimates

Jan 21, 2026, 12:15 PM EST - 16 days ago

Nasdaq Edges Lower; Johnson & Johnson Earnings Top Estimates


Johnson & Johnson reports Q4 and Full-Year 2025 results

Jan 21, 2026, 6:20 AM EST - 16 days ago

Johnson & Johnson reports Q4 and Full-Year 2025 results


Is Johnson & Johnson A Dividend Stock, Or Something Else?

Jan 19, 2026, 8:00 AM EST - 18 days ago

Is Johnson & Johnson A Dividend Stock, Or Something Else?


The 2026 Dogs Of The Dow: 10 High-Yield Blue Chips

Jan 11, 2026, 7:40 AM EST - 26 days ago

The 2026 Dogs Of The Dow: 10 High-Yield Blue Chips

AMGN CVX HD KO MRK NKE PG


Cramer's Mad Dash: Johnson & Johnson

Jan 9, 2026, 9:59 AM EST - 4 weeks ago

Cramer's Mad Dash: Johnson & Johnson


Best Dividend Aristocrats For January 2026

Dec 31, 2025, 8:47 AM EST - 5 weeks ago

Best Dividend Aristocrats For January 2026

ABBV ABT ADM ADP AFL ALB AMCR


The Big 3: JNJ, SNDK, TWLO

Dec 30, 2025, 1:31 PM EST - 5 weeks ago

The Big 3: JNJ, SNDK, TWLO

TWLO SNDK


CrystalW0lfe
CrystalW0lfe Feb. 6 at 7:12 PM
0 · Reply
CrystalW0lfe
CrystalW0lfe Feb. 6 at 6:22 PM
0 · Reply
TalkMarkets
TalkMarkets Feb. 6 at 5:57 PM
#JohnsonJohnson Is A Resilient Blue-Chip Stock And It Just Hit New All-Time Highs $JNJ https://talkmarkets.com/content/stocks--equities/johnson--johnson-is-a-resilient-blue-chip-stock-and-it-just-hit-new-all-time-highs?post=555570
0 · Reply
HydrogenH2
HydrogenH2 Feb. 6 at 5:15 PM
$JNJ I'm out !!
1 · Reply
CrystalW0lfe
CrystalW0lfe Feb. 6 at 4:38 PM
0 · Reply
LibertarianTreehugger
LibertarianTreehugger Feb. 6 at 4:32 PM
AbbVie CSO Touts ‘Breakthrough Type Therapy’ Psychedelic as J&J’s Spravato Keeps Growing $JNJ $CMPS $DFTX $ABBV https://www.biospace.com/drug-development/abbvie-cso-touts-breakthrough-type-therapy-psychedelic-as-j-js-spravato-keeps-growing.
1 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 6 at 2:38 PM
$JNJ RSI: 95.05, MACD: 7.3092 Vol: 9.09, MA20: 223.14, MA50: 213.24 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
CapitalGuidanceFramework
CapitalGuidanceFramework Feb. 6 at 2:18 PM
$XOM $JNJ Energy and healthcare leaders
0 · Reply
Fabiola_T
Fabiola_T Feb. 6 at 11:49 AM
$JNJ above 50D pressing new highs
0 · Reply
Suite510
Suite510 Feb. 6 at 3:49 AM
$JNJ $KVUE $UBER lol 😂 the party 🍿 just getting started 8.5M verdict-awarded-in-first-federal-trial-over-sexual-assault-of-uber-rider JNJ your turn now 😂🤓
1 · Reply
Rfras6885
Rfras6885 Feb. 6 at 1:42 AM
$JNJ air seems thin up here!
0 · Reply
blueblood12
blueblood12 Feb. 6 at 1:03 AM
$SPY $QQQ TrumpRx.gov 🌮 $JNJ $NVO $LLY look ready
0 · Reply
SniperPro
SniperPro Feb. 6 at 12:04 AM
$GILD $JNJ $LXRX $MRK $NFLX Welcome to my beautiful Greenland!!! DIVERSIFICATION IS KING!!!! Sometimes you just have to say.... FVCK IT!!!! Go With The Flow....
0 · Reply
InvestWithAaron
InvestWithAaron Feb. 5 at 11:48 PM
$JNJ The more health concerns over this stock market declines will only help this stock
0 · Reply
Shanatabodkin
Shanatabodkin Feb. 5 at 9:44 PM
$KO acts like the VIX. Goes up whe it does. Goes down like it doesn’t $JNJ close second.
0 · Reply
theoptionscoach
theoptionscoach Feb. 5 at 9:19 PM
$SPY $GOOG $CSCO $JNJ $QQQ Hello from theoptionscoach.net https://theoptionscoach.net/p/best-of-the-best-of-the-best
0 · Reply
viggizags
viggizags Feb. 5 at 8:19 PM
$BTC.X told yall just but dat $JNJ coin We all like what what in da butt i said what what in da butt
0 · Reply
RunnerSignals
RunnerSignals Feb. 5 at 8:13 PM
52-Week High Fever $JNJ $GSK $KO $GILD $ADI all tagging fresh 52-week highs
0 · Reply
FRAGMENTS
FRAGMENTS Feb. 5 at 7:16 PM
0 · Reply
A_Lilia
A_Lilia Feb. 5 at 5:16 PM
$JNJ breaking out
1 · Reply
Mahaperrotta
Mahaperrotta Feb. 5 at 3:10 PM
$MSFT Under $400 now? OK. This stock will be at least $475 to $500 a year from now. Low ball. That’s 18% to 25% gain. I’ll take it. Keep selling this and buy $JNJ
0 · Reply
FRAGMENTS
FRAGMENTS Feb. 5 at 1:03 PM
$XRP.X new Deep Value Report. This one is not a “do you like the macro” pitch. It’s a per-share asset file built from the balance sheet first, then stress-tested through the cycle. The market is treating HURC like a small cyclical that loses money, so nothing matters. The report treats it like what it is: an asset-heavy industrial where the only question is what the asset floor is worth per share while the cycle is ugly and what would confirm or kill that floor. HERE:https://cundilldeepvalue.substack.com/p/deep-value-report-hurco-companies If you care about asset floors, inventory realism, insider alignment, and disciplined Bear/Base/Bull bands, this is the report. $JNJ $PFE $MRK $KO
0 · Reply